C

CT Clinical Research | Cromwell, CT

Research site

(Unclaimed)

Location

160 West Street, Suite 1A, Cromwell, Connecticut, United States of America

Site insights

Top conditions

Top treatments

JZP150

BI 1569912

Cariprazine

Dasotraline

Pimavanserin

Zavegepant

BHV-3500

Quetiapine

Simufilam

BI 1358894

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 17 total trials

A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Elismetrep (K-304) in the Treatment of Migraine

This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep as compared to placebo in the treatme...

Enrolling

Acute Migraine

Drug: Placebo

Drug: Elismetrep (K-304) Dose level 3

A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

This study is open to people aged 18 years or older with schizophrenia. People can join the study if they are willing to use a smartphone app called...

Enrolling

Schizophrenia

Device: Digital therapeutic (CT-155)

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18...

Enrolling

Acute Treatment of Migraine

Drug: Rimegepant (PF-07899801)

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in chil...

Enrolling

Pediatric Migraine

Drug: Rimegepant/BHV3000

Drug: Matching placebo